I have always had this feeling that P was going to surprise everyone even though until recently it has been in the background. Considering how huge the market is for psoriasis and the very promising results of the Phase II, it sure seems reasonable to focus on getting it to an optimized dose and partnered as quickly as possible. If it is a much shorter term trial to get there (than K or and there is interest from BP, I say go all out on P and get it done. Dr. B certainly seems to have the credentials to do so and I credit Leo for setting aside his ego and getting Dr. B on board to take it there. Being able to adjust the strategy mid-stream like this when new information becomes available is a good sign in my opinion.

Go CTIX!